Skip to content

Effects of Lidocaine and Traditional Thai Acupressure Massage on Muscle Stiffness and Inflammatory Marker

The Effects of Lidocaine and Traditional Thai Acupressure Massage on Muscle Stiffness and Inflammatory Marker in Individuals With Active Upper Trapezius Trigger Points: A Randomized Comparative Trial with Single Blinded.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250616008
Enrollment
30
Registered
2025-06-16
Start date
2025-12-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with active myofascial trigger points (MTrPs) in the upper trapezius Lidocaine, Traditional Thai Massage , Muscle Stiffness, Inflammatory Marker, Substance P, Active Myofascial Trigger Points, Upper Trapezius

Interventions

Lidocaine trigger point injections were administered by a physician into active MTrPs of the upper trapezius muscle, using a single injection of 1 mL per session.,A traditional Thai massage program ta
Lidocaine,Traditional Thai Massage

Sponsors

Fundamental Fund 2026
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Male or female participants aged 30 to 50 years 2. Diagnosed with myofascial pain syndrome, and presenting with at least one active myofascial trigger point (MTrP) in the upper trapezius muscle 3. Chronic pain lasting more than 6 months 4. Pain intensity of 7 cm or higher on the Visual Analog Scale (VAS)

Exclusion criteria

Exclusion criteria: 1. Diagnosed with other musculoskeletal disorders in the neck and shoulder region, such as disc inflammation, herniation, degeneration, or nerve inflammation 2. Presence of conditions related to impaired circulation (e.g., uncontrolled diabetes, cardiovascular disease, or hypertension) 3. History of surgery in the neck or shoulder region 4. Currently taking anticoagulant medications (e.g., warfarin, enoxaparin, heparin) 5. Diagnosis of osteoporosis 6. Pregnant or suspected pregnancy 7. Subcutaneous fat thickness at the shoulder area >10 mm, as measured by ultrasound B-mode 8. Known allergy to lidocaine or related agents 9. Currently taking analgesics (e.g., NSAIDs), considering the pharmacological activity window of each drug

Design outcomes

Primary

MeasureTime frame
Muscle stiffness 1) Baseline; 2) immediately after treatment 1 session; 3) short term at 1 day after receive the last treatment session. Ultrasound Shear Wave Elastography, Cortisol level 1) Baseline; 2) immediately after treatment 1 session; 3) short term at 1 day after receive the last treatment session. Salivary Cortisol

Secondary

MeasureTime frame
Pain intensity 1) Baseline; 2) immediately after treatment 1 session; 3) short term at 1 day after receive the last treatment session. Visual Analog Scale,Pressure Pain Threshold 1) Baseline; 2) immediately after treatment 1 session; 3) short term at 1 day after receive the last treatment session. Tissue Hardness Meter and Algometer,Tissue Hardness 1) Baseline; 2) immediately after treatment 1 session; 3) short term at 1 day after receive the last treatment session. MyotonPRO,Cervical Range of Motion 1) Baseline; 2) immediately after treatment 1 session; 3) short term at 1 day after receive the last treatment session. CROM,Neck Disability Index 1) Baseline; 2) short term at 1 day after receive the last treatment session. NDI-Thai version

Countries

Thailand

Contacts

Public Contactwiraphong sucharit

Khon Kaen University

wirasu@kku.ac.th0910595452

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026